Model
Edge
Oncocyte Corporation
OCX
Filing Type
8-K
Filing Date
10/1/2025
Updated
10/2/25, 10:05 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation
EX-10.1
EX-10.1